Copyright
©The Author(s) 2017.
World J Gastrointest Endosc. Apr 16, 2017; 9(4): 189-195
Published online Apr 16, 2017. doi: 10.4253/wjge.v9.i4.189
Published online Apr 16, 2017. doi: 10.4253/wjge.v9.i4.189
Table 4 Univariate analyses of clinical data and endoscopic retrograde cholangiopancreatography intervention for post- endoscopic retrograde cholangiopancreatography pancreatitis
| Variables | No. of patients (n = 121) | Median of patients (range) | Univariate analysis P value |
| ERCP procedure | 0.429 | ||
| Not emergency/emergency | 104/17 | ||
| EST | 31 | 0.302 | |
| EPBD | 14 | 0.736 | |
| Pancreatography | 0.798 | ||
| No/yes | 47/74 | ||
| Contrast media remained in the pancreatic duct | 0.011 | ||
| No/yes | 80/41 | ||
| IDUS | 0.168 | ||
| No/yes | 95/26 | ||
| Transpapillary biopsies | 0.975 | ||
| No/yes | 86/35 | ||
| Time for ERCP procedure (min) | 50 (12-170) | 0.343 | |
| Expertise of ERCP procedure | 0.65 | ||
| Not expert/expert | 71/50 | ||
| Abdominal pain within three hours after ERCP | 0.006 | ||
| No/yes | 50/51 | ||
| Serum amylase level of the next day (IU/mL) | 1065 (83-3604) | 0.184 | |
| White blood cell of the next day (/μL) | 8050 (3240-26320) | 0.668 | |
| C-reactive protein of the next day (mg/dL) | 2.1 (0.04-38.31) | 0.601 |
- Citation: Matsubara H, Urano F, Kinoshita Y, Okamura S, Kawashima H, Goto H, Hirooka Y. Analysis of the risk factors for severity in post endoscopic retrograde cholangiopancreatography pancreatitis: The indication of prophylactic treatments. World J Gastrointest Endosc 2017; 9(4): 189-195
- URL: https://www.wjgnet.com/1948-5190/full/v9/i4/189.htm
- DOI: https://dx.doi.org/10.4253/wjge.v9.i4.189